Solomon Langermann
18Patents
8h-index
18Co-inventors
69Inventor score
Filing activity: Apr 23, 1999 → Jan 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8609089B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 131 | Active |
| US8709416B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 86 | Active |
| US8114845B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 68 | Active |
| US9205148B2 | Antibodies and other molecules that bind B7-H1 and PD-1 | Chemistry; Metallurgy | 66 | Active |
| US9574000B2 | Anti-human B7-H4 antibodies and their uses | Chemistry; Metallurgy | 16 | Active |
| US6500434B1 | Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6737063B2 | FimH adhesin proteins and methods of use | Human Necessities | 10 | Expired |
| US9676854B2 | Anti-B7-H4 antibodies and their uses | Chemistry; Metallurgy | 9 | Active |
| US6368599B1 | Caulobacter LPS immunoadjuvants | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6913750B2 | Therapeutic compounds structurally-linked to bacterial polypeptides | Chemistry; Metallurgy | 6 | Expired |
| US9005616B2 | Methods and compositions for the inhibition of transplant rejection | Physics | 6 | Active |
| US9011853B2 | B7-H4 fusion proteins and methods of use thereof | Physics | 5 | Active |
| US9957312B2 | B7-H4 fusion proteins and methods of use thereof | Physics | 3 | Active |
| US10316092B2 | Anti-B7-H5 antibodies and their uses | Chemistry; Metallurgy | 2 | Active |
| US12084495B2 | Compositions and methods for modulating LAIR signal transduction | Chemistry; Metallurgy | 0 | Active |
| US12286478B2 | B7-H4 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11390675B2 | Antibodies for Siglec-15 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9790277B2 | Anti-H7CR antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.